Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions

No abstract is available for this paper.

• Publication year

  1973

• Venue

  International Journal of Cancer

• Publication date

  1973-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.2910120109PMID 4790711
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular and humoral immunity to rat hepatoma‐specific antigens correlated with tumour status

  1973cited by this paper
• Detection of Circulating Hepatoma D23 Antigen and Immune Complexes in Tumour Bearer Serum

  1973cited by this paper
• Fractionation of plasma membrane‐associated tumour‐specific antigen from an aminoazo dye‐induced rat hepatoma

  1973cited by this paper
• Inhibition of hepatoma‐immune lymph‐node cell cytotoxicity by tumour‐bearer serum, and solubilized hepatoma antigen

  1973cited by this paper
• The Presence of Tumour Specific Membrane Antigen in the Serum of Rats with Chemically Induced Sarcomata

  1973cited by this paper
• Cell‐mediated and humoral immune reactions to human tumours

  1973cited by this paper
• Separation of Skin Reactive Intestinal Cancer Antigen from the Carcinoembryonic Antigen of Gold

  1972cited by this paper
• Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.

  1972cited by this paper
• Elution of “blocking factors” from human tumors, capable of abrogating tumor‐cell destruction by specifically immune lymphocytes

  1972cited by this paper
• Solubilization of tumour-specific antigen from plasma membrane of an aminoazo-dye-induced rat hepatoma.

  1972cited by this paper
• Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review.

  1972cited by this paper
• Serum Mediated Inhibition of the Immunological Reactions of the Patient to his Own Tumour: A Possible Role for Circulating Antigen

  1972cited by this paper
• Antigens in Virally Induced Tumors

  1971cited by this paper
• Immunization with Irradiated Tumour Cells and Specific Lymphocyte Cytotoxicity in Malignant Melanoma

  1971cited by this paper
• Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

  1971cited by this paper
• Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

  1971cited by this paper
• Demonstration of cell‐mediated immunity to human neoplasms of various histological types

  1971cited by this paper
• Colony inhibition studies on blocking and non‐blocking serum effects on cellular immunity to moloney sarcomas

  1970cited by this paper
• Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens.

  1970cited by this paper
• Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas.

  1970cited by this paper
• Cellular and humoral immune responses to human urinary bladder carcinomas

  1970cited by this paper
• Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens.

  1969cited by this paper
• The cellular immune response to primary sarcomata in rats II. Abnormal responses of nodes draining the tumour

  1969cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Noncytolytic extraction of cell surface antigens using butanol

  2004cites this paper
• Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis.

  1997cites this paper
• Pharmacokinetics: defining dosimetry for risk assessment. March 4-5, 1992, Washington, DC. Proceedings.

  1994cites this paper
• Immunology of Malignant Diseases

  1987cites this paper
• Immunology in Bowel Cancer

  1987cites this paper
• Shedding eucaryotic cells.

  1983cites this paper
• Gastrointestinal Cancer Markers

  1982cites this paper
• Escape of Tumours from Immunological Destruction

  1982cites this paper
• Association of impaired immune responsiveness of lymphocytes from animals bearing large tumors with a membrane-bound suppressive substance.

  1982cites this paper
• [Effect of Ulceration and lymph node metastasis of skin melanomas on the germinal centers of regional lymph nodes].

  1982cites this paper
• Radioiodination of rat hepatoma-specific antigens and retention of serological reactivity.

  1980cites this paper
• Impairment of systemic concomitant antitumor immunity by excess soluble tumor antigen

  1980cites this paper
• Human malignant melanoma: assay of tumor associated antigens by use of rabbit antisera.

  1980cites this paper
• [Relapse prognosis for patients with adenocarcinoma of the gastrointestinal tract on the basis of carcinoembryonic antigen (CEA) and its circulating immune complexes (author's transl)].

  1980cites this paper
• Rezidivprognosen bei Patienten mit Adenocarcinomen des Gastrointestinaltraktes auf der Basis von Carcinoembryonalem Antigen (CEA) und seinen zirkulierenden Immunkomplexen

  1980cites this paper
• Certain aspects of analysis of complement dependent antibody in breast cancer patients

  1979cites this paper
• Pre and post operative changes in lymphocyte mediated cytotoxicity and serum blocking factor on human colon cancer

  1979cites this paper
• Circulating immune complexes in colon cancer patient sera

  1979cites this paper
• Diamond‐Blackfan Syndrome: Evidence for T‐Cell Mediated Suppression of Erythroid Development and a Serum Blocking Factor Associated with Remission

  1979cites this paper
• Immune modulation and cancer control.

  1978cites this paper
• Analysis of serum blocking factors against leukocyte‐dependent antibody in melanoma patients

  1978cites this paper
• White cell stimulation responses to 3MK Cl extracts of allogeneic tumours in lung and colorectal cancer.

  1978cites this paper
• Experimental colon cancer.

  1978cites this paper
• In vitro testing of the immune response

  1978cites this paper
• Recognitive Immunity in Colon Cancer

  1978cites this paper
• Adjuvant Chemotherapy and Immunotherapy in Colorectal Cancer

  1978cites this paper
• Human tumour-associated antigens: methods of in vitro detection

  1978cites this paper
• The LMI assay in lung and colorectal cancer: the use of allogeneic extracts prepared by different methods.

  1978cites this paper
• Circulating factors modifying cell-mediated immunity in experimental neoplasia

  1978cites this paper
• Lymphocyte cytotoxicity in x-irradiation-induced rat small bowel adenocarcinoma. III. Blocking by 3 M KCL extract.

  1978cites this paper
• Immunological Aspects of Cancer

  1978cites this paper
• Of mice and men in bone marrow transplantation.

  1977cites this paper
• Ability of renal carcinoma tissue extract to induce leukocyte migration inhibition in patients with nonmetastatic renal carcinoma: Correlation with clinical and histopathological findings

  1977cites this paper
• [Available methods to modify primary graft rejection (author's transl)].

  1977cites this paper
• [Significance of immunologic defects for neoplasm development].

  1977cites this paper
• Modification by soluble antigen of the immune response to mycobacterial infection

  1977cites this paper
• Colorectal cancer diagnosis by a direct leukocyte migration test using a panel of tumour extracts

  1977cites this paper
• Serum IgA and emotional expression in breast cancer patients.

  1977cites this paper
• Cell-mediated cytotoxicity in vitro of human lymphocytes against a cervical cancer cell line.

  1977cites this paper
• Binding of colonic tissue membrane to mononuclear peripheral blood leukocytes.

  1977cites this paper
• The significance of cytotoxicity of lymphocyte populations in coloncarcinoma patients in comparison to normal controls using a new statistical method of evaluation.

  1977cites this paper
• 8 – Shedding of tumor cell surface antigens

  1977cites this paper
• Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients.

  1977cites this paper
• Tumor-related blocking of anti-fetal immunity.

  1977cites this paper
• Blocking of oncofoetal cross-reactivity in human osteogenic sarcoma with solubilized tumour antigen.

  1977cites this paper
• Active specific immunotherapy potential for the treatment of large bowel cancer

  1977cites this paper
• In vitro assessment of cell-mediated immunity in patients with renal cell carcinoma.

  1976cites this paper
• Humoral factors in specific unresponsiveness to transplantation antigens.

  1976cites this paper
• Lymphocytotoxicity to tumor target cells and interference, of serum factors or tumor antigen with lymphocytotoxicity in patients suffering from different stages of breast carcinoma

  1976cites this paper
• Fetal antigens in human digestive tumors.

  1976cites this paper
• Effect of leucocyte washings on cellular immunity to human renal carcinoma.

  1976cites this paper
• Factors interfering with immunological rejection of tumours.

  1976cites this paper
• Membrane‐associated antigen from the SV40‐induced hamster fibrosarcoma, para‐7. I. Role in immune complex fcrmation and effector cell blockade

  1976cites this paper
• Cell surface alterations on colon adenocarcinoma cells.

  1976cites this paper
• Use of soluble histocompatibility antigen(s) in the control of transplantation reactions: possible dissociation of the roles of H-2 and non-H-2 antigens in the prevention of mortality induced by graft-versus-host reaction.

  1976cites this paper
• Chronic mucocutaneous candidosis: A review

  1976cites this paper
• Antibody-dependent cell-mediated cytotoxicity against melanoma cells induced by plasmapheresis.

  1976cites this paper
• Tumor antigen extracts stimulate cytotoxicity against unrelated target cells

  1976cites this paper
• Human colonic adenocarcinoma cells

  1976cites this paper
• ISOLATION AND CHARACTERIZATION OF TUMOUR‐SPECIFIC ANTIGEN FROM THE SERUM OF RATS BEARING TRANSPLANTED AMINOAZO DYE‐INDUCED HEPATOMAS

  1976cites this paper
• Problems in the use of in vitro assays for monitoring cell-mediated immunity in cancer patients.

  1976cites this paper
• Nature and Expression of Tumour Antigens Associated with Experimental Animal and Human Tumours

  1976cites this paper
• Immunotherapy of gastrointestinal cancer: the potential.

  1976cites this paper
• Humoral immunity in malignant skin melanoma. Isolation of melanoma specific IgG from melanoma metastases.

  1976cites this paper
• Immunological aspects of colorectal cancer.

  1976cites this paper
• Tumor antigens and tumor-host relationships.

  1976cites this paper
• Specific removal of circulating antigen by means of immunoadsorption

  1976cites this paper
• Efferent enhancement of a methylcholanthrene‐induced Sarcoma transplantable in strain 13 guinea pigs

  1976cites this paper
• The role of immunology in the diagnosis, prognosis and treatment planning of oral cancer.

  1976cites this paper
• Biological Basis:Tumour Associated Antigens, the Immune Machinery, and Its Behaviour Concerning Cancer Cells

  1976cites this paper
• Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens

  1975cites this paper
• Host Immune Response to Human Tumor Antigens

  1975cites this paper
• [Carcinofetal antigens. III. Further carcinofetal antigens (author's transl)].

  1975cites this paper
• Immunobiology of Chemically Induced Tumors

  1975cites this paper
• Purification of tumor associated antigens from a methylcholanthrene induced murine sarcoma as monitored by humoral cytotoxicity.

  1975cites this paper
• Frontiers in inflammatory bowel disease

  1975cites this paper
• Characterization of a chimpanzee anti-human melanoma antiserum.

  1975cites this paper
• Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients.

  1975cites this paper
• Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part II.

  1975cites this paper
• Tumorimmunologische Untersuchungen bei Coloncarcinom

  1975cites this paper
• Immunology, virology, and cancer.

  1975cites this paper
• Tumor‐associated and embryonic antigens in soluble fractions of a chemically‐induced rat colon carcinoma

  1975cites this paper
• Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma.

  1975cites this paper
• Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells.

  1975cites this paper
• Onco-foetal cross reactivity between human osteogenic sarcoma and foetal periosteal fibroblasts grown 'in vitro'.

  1975cites this paper
• Serum factors modifying cell mediated immunity to rat hepatoma D23 correlated with tumour growth

  1975cites this paper
• Early onset of serum blocking in a murine melanoma model

  1975cites this paper
• In vitro assays of cell-mediated immunity to human solid tumors: problems of quantitation, specificity, and interpretation.

  1975cites this paper
• Frontiers in inflammatory bowel disease

  1975cites this paper
• Development of two manifestations of T-lymphocyte reactivity during tumor growth: altered kinetics associated with elevated growth rates.

  1975cites this paper
• The immunologic and histopathologic changes of BCG‐mediated tumor regression in patients with malignant melanoma

  1975cites this paper
• Carcinofetale Antigene

  1975cites this paper
• In vitro „education”︁ on autologous human sarcoma generates non‐specific killer cells

  1975cites this paper
• Purification of tumor‐specific antigens. An overview of the relevance to human colon carcinoma

  1975cites this paper
• Membrane associated antigens of human malignant melanoma. I. Internal labeling, detergent solubilization and characterization by homologous antisera and polyacrylamide gel electrophoresis.

  1975cites this paper
• Lymphocyte response to autologous tumor antigen(S) and phytohemagglutinin in ovarian cancer patients

  1975cites this paper
• Immunopotentiation with BCG: dimensions of a specific antitumor response.

  1975cites this paper
• Large bowel cancer: causation and management.

  1975cites this paper
• Approaches to immunotherapy

  1974cites this paper
• Tumorimmunologische Phänomene: Theoretische Grundlagen, klinische Bedeutung

  1974cites this paper